Cargando…
Veverimer: an advance in base therapy for metabolic acidosis
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661860/ https://www.ncbi.nlm.nih.gov/pubmed/33209911 http://dx.doi.org/10.21037/atm-20-2827 |
_version_ | 1783609283437395968 |
---|---|
author | Brady, Clayton Chemaly, Elie R. Lohr, James W. Parker, Mark D. |
author_facet | Brady, Clayton Chemaly, Elie R. Lohr, James W. Parker, Mark D. |
author_sort | Brady, Clayton |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7661860 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-76618602020-11-17 Veverimer: an advance in base therapy for metabolic acidosis Brady, Clayton Chemaly, Elie R. Lohr, James W. Parker, Mark D. Ann Transl Med Editorial Commentary AME Publishing Company 2020-10 /pmc/articles/PMC7661860/ /pubmed/33209911 http://dx.doi.org/10.21037/atm-20-2827 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Editorial Commentary Brady, Clayton Chemaly, Elie R. Lohr, James W. Parker, Mark D. Veverimer: an advance in base therapy for metabolic acidosis |
title | Veverimer: an advance in base therapy for metabolic acidosis |
title_full | Veverimer: an advance in base therapy for metabolic acidosis |
title_fullStr | Veverimer: an advance in base therapy for metabolic acidosis |
title_full_unstemmed | Veverimer: an advance in base therapy for metabolic acidosis |
title_short | Veverimer: an advance in base therapy for metabolic acidosis |
title_sort | veverimer: an advance in base therapy for metabolic acidosis |
topic | Editorial Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661860/ https://www.ncbi.nlm.nih.gov/pubmed/33209911 http://dx.doi.org/10.21037/atm-20-2827 |
work_keys_str_mv | AT bradyclayton veverimeranadvanceinbasetherapyformetabolicacidosis AT chemalyelier veverimeranadvanceinbasetherapyformetabolicacidosis AT lohrjamesw veverimeranadvanceinbasetherapyformetabolicacidosis AT parkermarkd veverimeranadvanceinbasetherapyformetabolicacidosis |